By Kim Longfield, Director of Research, PSI
The Global Health & Innovation Conference is the world’s leading global health and social entrepreneurship conference. Held in New Haven, Conn., last week, the tenth edition of the gathering attracted more than 2,000 delegates and speakers from an array of disciplines: global health leaders like Jeffrey Sachs; investigative journalists like Michael Moss; influential bloggers like Seth Godin; and activists, entrepreneurs, academics, students, donors, and implementers.
It was the first time I’ve presented at this prestigious conference.
Dr. Aye Aye owns a small, tin roof clinic nestled next to her home in Yangon, Myanmar. There she serves the poor of her community with integrated health services including family planning, tuberculosis screening and treatment, diarrhea treatment, and more. She was one of the first doctors to join the Sun Quality Health Network, PSI/Myanmar’s social franchise network.
There is a global shortage of 7.2 million doctors, nurses, and midwives, according to new estimates by the World Health Organization. By 2035, that number could reach 12.9 million. We missed the opportunity to make health workers part of the Millennium Development Goals in 2000—we should not miss it again.
UNICEF and PSI have teamed up to develop a community of practice focused on using micronutrient powders at home.
Access to contraception is something we often take for granted in the United States. But 222 million women in the developing world – who have an unmet need for contraception – still can’t get it. How can contraception radically change their worlds?
By Karl Hofmann, President & CEO, PSI; Steve Davis, President & CEO, PATH; and Raj Kumar, president, Devex.
Knowing where to invest time, resources and funding to have the greatest impact in this complex environment can be difficult. To inform these decisions, Devex, in partnership with PSI and PATH, conducted a survey to highlight smart investments in global health. We surveyed nearly 1,500 experts working in global health to learn what they think are the smartest investments — or “best buys” — to achieve our public health goals.
Marking the launch of the Spring edition of PSI’s Impact Magazine, “The Best Buys Issue: Where to Invest in Global Health in 2014,” two panels of global health industry leaders gathered to discuss what are the best buys for global health. View the video of the full event, and the conversation on Twitter. Here’s more information about the event, hosted in partnership with PATH, Devex, and the Center for Global Development, with support from the Merck for Mothers Program.
To have real and lasting impact, we must step back from the intervention level of analysis to understand how we can mold entire ecosystems to better serve the health of broad populations. Sometimes this is called ‘health systems strengthening’, and sometimes it might be seen under the even broader rubric of ‘capacity building’.
Half the hospital beds in developing countries are filled with people suffering from diseases caused by poor water, sanitation and hygiene. So are water, sanitation, and hygiene projects a “Best Buy for Global Health?” You’ll have to tune in tomorrow from 3-5 p.m. to find out!
Human papillomavirus (HPV) is the most common viral infection of the reproductuve tract, according to the WHO. There is good news: record low prices for the HPV vaccine “has opened the door for poor countries to vaccinate millions of girls against a devastating women’s cancer.” Social marketing could play a vital role in taking advantage of that opportunity, according to a new study from PLoS One.